Abstract View

Author(s): Soham Mandal*1, Moumita karmakar2

Email(s): 1soham.mandal@tnu.in

Address:

    Department of pharmaceutics, School of Pharmacy, The Neotia University, West Bengal.

Published In:   Volume - 2,      Issue - 3,     Year - 2023

DOI: Not Available

 View HTML        View PDF

Please allow Pop-Up for this website to view PDF file.

ABSTRACT:
In industrialised nations, cardiovascular disease (CVD) is the vital cause of death and morbidity. Atherosclerotic lesions that narrow the arterial lumen are the cause of CVD. Development of plaque, reduces blood flow to the heart and usually causes serious consequences. Medication delivery methods alter the drug release profile, absorption, and distribution to treat various disorders while enhancing the effectiveness and safety of the final product. In the rapidly developing field of nanomedicine, materials on the nanoscale are employed as therapeutic agents. The nano-drug delivery system has distinguished itself as an excellent platform for delivering therapeutic agents to a sick location in a more regulated and targeted manner among all the other fascinating uses of nanomaterials. Through site-specificity, reduced toxicity, and target-oriented administration, nanotechnology aims to treat terrifying illnesses while providing various advantages. This review discusses new computer simulations of magnetically targeted nano-pharmacodynamics, nanoparticles, and nano-drug delivery devices.

Cite this article:
Soham Mandal*, Moumita karmakar. Computational Nano- Pharmacodynamics in Cardiovascular Diseases. IJRPAS, March-April 2023; 2(2): 35-43


References not available.

Related Images:



Recent Images



Evaluation of In-Vitro Anti-Diabetic Activity And   Antioxidant Activity In Ethanolic and Hydroalcoholic Extract of leaves of Gymnema Sylvestre
Molecular Docking Approaches in Antibacterial Drug Discovery: Computational Insights into Natural Compounds
In-vitro Evaluation of Anti-Urolithiatic Activity of Hydroalcoholic Extract of Centella asiatica Leaves
Quality by Design (Qbd) Based Method Development and Validation of Trelagliptin Succinate byu RP-HPLC.
Cubosomes: Structure, Preparation Methods, Characterization, and Pharmaceutical Applications
Programmable Oral Drug Delivery Systems: Materials, Device Engineering, Stimuli-Responsive Mechanisms, and Clinical Translation
Biomimetic Nanocarrier for Targeted Drug Delivery: An Integrated Review
From Phosphate Wasting to Targeted Therapy: An Updated Review of FGF23-Mediated Hypophosphatemic Rickets
Nanotechnology-Based Drug Delivery Systems for Alzheimer’s Disease: Emerging Strategies for Blood–Brain Barrier Targeting
Explainable AI in Pharmacy: Building Trust in AI-Based Drug Recommendation

Tags